Patents for C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes (141,535) |
---|
11/23/2010 | US7838651 nucleotide sequences comprising a Yarrowia genetic translation initiation site, for encoding desaturases |
11/23/2010 | US7838649 Isolated nucleic acid molecule encoding an amino acid sequence with beta -ketoacyl-ACP synthase (KS) activity; polyunsaturated fatty acid (PUFA) polyketide synthase (PKS) systems from bacterial microorganisms ; plants and microorganisms that produce lipids |
11/23/2010 | US7838632 Maize cellulose synthases and uses thereof |
11/23/2010 | US7838294 Inhibitors of the JNK signal transduction pathway and methods of use |
11/23/2010 | US7838279 Production of isoprenoids |
11/23/2010 | US7838278 Compositions and methods for manipulating carbon flux in cells |
11/23/2010 | US7838276 Carbohydrate utilization-related and multidrug transporter nucleic acids and polypeptides; producing a polypeptide by culturing a microbial cell that has beta-galactosidase activity; Lactobacillus acidophilus |
11/23/2010 | US7838275 Anti-HIV and anti-tumor peptides and fragments of lysozyme |
11/23/2010 | US7838274 polynucleotides encoding the phospholipases; using these enzymes in industrial processes and methods of diagnosing fungal infections; Aspergillus niger; recombinant host cells wherein the expression of a phospholipase is significantly increased or wherein the activity of the phospholipase is increased |
11/23/2010 | US7838273 fabricating novel hybrid materials comprised of carbon nanotubes (CNTs) and crosslinked enzyme clusters (CECs); CEC-enzyme-CNT hybrids exhibit high activity per unit area or mass as well as improved enzyme stability and longevity; highly stable and exhibits high activity |
11/23/2010 | US7838271 Microbiological method for producing amides |
11/23/2010 | US7838270 Using viron polymerase to detect and quantify one or multiple target nucleic acid sequences including target sequences that differ by as little as one nucleotide; diagnostic sequencing |
11/23/2010 | US7838266 A purified pro-cytolytic peptide; used to treat localized and metastatic prostate cancer; administered intratumorally and/or intraprostatically |
11/23/2010 | US7838265 Compositions of aminoacyl-tRNA synthetase and uses thereof |
11/23/2010 | US7838255 Nucleic acids and polypeptides of C1 bacteriophage and uses thereof |
11/23/2010 | US7838237 predicting in an individual the likelihood of developing cancer; genotyping; familial adenomatous polyposis (FAP), attenuated FAP (AFAP), or hereditary non-polyposis colorectal cancer (HNPCC) syndrome |
11/23/2010 | US7838230 Assay for measuring an enzyme's capability to modify supercoil topology of nucleic acids and modulators |
11/23/2010 | US7838207 Surrogate cell-based system and method for assaying the activity of hepatitis C virus NS3 protease |
11/23/2010 | US7838053 Barley for production of flavor-stable beverage |
11/23/2010 | US7837997 Compositions and methods for prevention and treatment of uncontrolled formation of intravascular fibrin clots |
11/23/2010 | US7837992 C-1 inhibitor prevents non-specific plasminogen activation by a prourokinase mutant without impeding fibrin-specific fibrinolysis |
11/23/2010 | CA2444529C Micellar drug delivery systems for hydrophobic drugs |
11/23/2010 | CA2337981C Gene participating in the production of homoglutamic acid and its use |
11/23/2010 | CA2263823C Mammalian artificial chromosomes |
11/23/2010 | CA2209301C Redirection of cellular immunity by protein-tyrosine kinase chimeras |
11/18/2010 | WO2010131195A1 Phosphodiesterase 4d7 as prostate cancer marker |
11/18/2010 | WO2010131194A1 Phosphodiesterase 4d7 as marker for malignant, hormone-sensitive prostate cancer |
11/18/2010 | WO2010131193A1 Phosphodiesterase 9a as prostate cancer marker |
11/18/2010 | WO2010130864A1 Modified reverse transcriptase of hiv-1 group o |
11/18/2010 | WO2010130862A1 High redox potential peroxidases designed by directed evolution |
11/18/2010 | WO2010130810A1 Extracellular yaluronidase from streptomyces koganeiensis |
11/18/2010 | WO2010130806A1 Recombinant bacteria and the uses thereof for producing ethanol |
11/18/2010 | WO2010130725A1 Acyltransferases and uses thereof in fatty acid production |
11/18/2010 | WO2010085101A3 Novel lipases induced by fasting |
11/18/2010 | WO2010084387A3 Stable aqueous antimicrobial enzyme compositions |
11/18/2010 | WO2010046142A3 A method of obtaining high level disinfection in a washer disinfector, and a washer disinfector |
11/18/2010 | WO2009146464A3 Methods and compositions for modifying levels of lignin and increasing the digestibility of cellulose by the recombinant overexpression of lignocellulolytic enzymes |
11/18/2010 | US20100293674 Transgenic plants expressing recombinant barley alanine aminotransferase |
11/18/2010 | US20100293669 Nucleic Acid Molecules and Other Molecules Associated with Plants and Uses Thereof for Plant Improvement |
11/18/2010 | US20100293666 Method of selectively producing male or female sterile plants |
11/18/2010 | US20100292461 Plant cells and plants which synthesize a starch with an increased final viscosity |
11/18/2010 | US20100292179 Target |
11/18/2010 | US20100292142 Novel neurotrophic factors |
11/18/2010 | US20100292137 Antibiotics and Methods For Producing Them |
11/18/2010 | US20100292130 Biological active proteins having increased in vivo and/or in vitro stability |
11/18/2010 | US20100291682 System for transposing hyperactive recombinant derivatives of mos-1 transposon |
11/18/2010 | US20100291680 Methods and compositions for inhibition of membrane fusion-associated events, including hiv transmission |
11/18/2010 | US20100291657 Ribonucleases in which an amino acid sequence of a known ribonuclease is preceded by at least one residue at the n-terminus, and methods of making them recombinantly |
11/18/2010 | US20100291656 Method and system for protein purification |
11/18/2010 | US20100291655 Novel glucose dehydrogenase and method for producing the dehydrogenase |
11/18/2010 | US20100291651 Recombinant hydrogen-producing cyanobacterium and uses thereof |
11/18/2010 | US20100291645 Xylose reductase mutants and uses thereof |
11/18/2010 | US20100291643 Method for producing enationmerically pure d-ppt |
11/18/2010 | US20100291642 Process For Preparing Dipeptidyl Peptidase IV Inhibitors And Intermediates Therefor |
11/18/2010 | US20100291638 Thermostable dna polymerases and methods of use |
11/18/2010 | US20100291635 Chimeric primers for improved nucleic acid amplification reactions |
11/18/2010 | US20100291631 Novel Beta-Galactoside-Alpha 2,3-Sialyltransferase, a Gene Encoding Thereof, and a Method for Producing Thereof |
11/18/2010 | US20100291621 Anaerobic process |
11/18/2010 | US20100291616 Novel genes, compositions, kits, and methods for identification, assessment, prevention and therapy of cervical cancer |
11/18/2010 | US20100291608 Novel gtp cyclohydrolase type ib |
11/18/2010 | US20100291607 Transformed cell with enhanced sensitivity to antifungal compound and use thereof |
11/18/2010 | US20100291586 Method for the diagnosis or the screening of an arbovirus infection, reagents useful in said method and their applications |
11/18/2010 | US20100291564 Methods for Detection of Micro-Organisms |
11/18/2010 | US20100291559 Compositions of orthogonal lysyl-tRNA and aminoacyl-tRNA synthetase pairs and uses thereof |
11/18/2010 | US20100291556 Isolated aebp1 genomic polynucleotide fragments from chomosome 7 and their uses |
11/18/2010 | US20100291555 Primer and probe for detection of mycobacterium avium and method for detection of mycobacterium avium by using the primer or probe |
11/18/2010 | US20100291550 Methods and compositions for modulating hair growth |
11/18/2010 | US20100291262 Lipolytic Enzyme Variants |
11/18/2010 | US20100291189 Method for producing a membrane protein |
11/18/2010 | US20100291153 Vaccines against bordetella pertussis based on lps glycosyltransferase mutants |
11/18/2010 | US20100291139 Recombinant mva virus and the use thereof |
11/18/2010 | US20100291127 Tumor associated antigen peptides and use of same as anti-tumor vaccines |
11/18/2010 | US20100291114 Crystal structures and methods using same |
11/18/2010 | US20100291099 Novel 27411, 23413, 22438, 23553, 25278, 26212, narc sc1, narc 10a, narc 1, narc 12, narc 13, narc17, narc 25, narc 3, narc 4, narc 7, narc 8, narc 11, narc 14a, narc 15, narc 16, narc 19, narc 20, narc 26, narc 27, narc 28, narc 30, narc 5, narc 6, narc 9, narc 10c, narc 8b, narc 9, narc2a, narc 16b, narc 1c, narc 1a, narc 25, 86604 and 32222 molecules and uses therefor |
11/18/2010 | US20100291063 Protease inhibition |
11/18/2010 | US20100291059 Pharmaceutical composition for enzyme replacement therapy |
11/18/2010 | US20100291001 Metalloproteinase-binding proteins |
11/18/2010 | US20100290987 Methods and compositions for detecting and modulating o-glycosylation |
11/18/2010 | CA2761605A1 Use of lipid conjugates in the treatment of diseases associated with vasculature |
11/18/2010 | CA2760727A1 Recombinant bacteria and the uses thereof for producing ethanol |
11/18/2010 | CA2760326A1 Acyltransferases and uses thereof in fatty acid production |
11/18/2010 | CA2759373A1 Extracellular yaluronidase from streptomyces koganeiensis |
11/17/2010 | EP2251426A1 Mammalian-type glycosylation in plants |
11/17/2010 | EP2251421A1 Stabilized transglutaminase and process for production thereof |
11/17/2010 | EP2251420A1 Thermostable mutants of pyrroloquinoline quinone dependent glucose dehydrogenase |
11/17/2010 | EP2251415A1 Recombinant bacteria and the uses thereof for producing ethanol |
11/17/2010 | EP2251347A2 Methods for the production of ASLV reverse transcriptases composed of multiple subunits |
11/17/2010 | EP2251024A1 Plant-origin drug for preventing or improving hyperuricemia |
11/17/2010 | EP2250885A2 Novel alpha-galactosidases |
11/17/2010 | EP2250884A2 Novel alpha-galactosidases |
11/17/2010 | EP2250263A1 A pentose sugar fermenting cell |
11/17/2010 | EP2250262A1 A pentose sugar fermenting cell |
11/17/2010 | EP2250261A1 Crystal structure of pfa-mi and the pfa-mi co4 complex |
11/17/2010 | EP2250260A1 Chitinosanase |
11/17/2010 | EP2250259A1 Polypeptides having lipase activity and polynucleotides encoding same |
11/17/2010 | EP2250258A2 Lipolytic enzyme variant with improved stability and polynucleotides encoding same |
11/17/2010 | EP2250257A1 Expression of catalase in trichoderma |
11/17/2010 | EP2250195A1 Sulfatase enzymes |
11/17/2010 | EP2249864A2 Strategies to prevent and/or treat immune resuponses to soluble allofactors |
11/17/2010 | EP2249863A1 Method of improving wound healing |